Jun 2026 (Q2 FY26) — Aug 11, 2026
Bain Capital Specialty Finance Q2 FY26 — Solid NII and Healthy Credit Fundamentals
Read the full callBain Capital Specialty Finance (BCSF) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Bain Capital Specialty Finance earnings: last reported Tue, 11 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | Quarterly, as filed | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | 14.1 | −40.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$10.26 −3.48% · −$0.37
Performance −26.7% 1Y
1Y: $13.99 on 15 Oct 2025 → $10.26. High $14.6 (10 Dec 2025), low $10.26 (16 Oct 2026).
- Previous close
- $10.63
- 52-week range
- $10.26 – $14.6
- One year
- −24.89%
Overview
- Symbol
- BCSF
- Sector
- Financials
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Bain Capital Specialty Finance earnings calls (BCSF)
Financials
What the filings say
Net profit, year on year: −41% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Interest | 18 | 21 | 19 | 22 | 20 | 20 | 20 | 21 |
| Net profit | 33 | 22 | 29 | 24 | 19 | 28 | 3 | 14 |
| EPS ($ per share) | 0.51 | 0.34 | 0.44 | 0.37 | 0.29 | 0.43 | 0.05 | 0.22 |
| Line item | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 | 0 |
| Reserves | — | — | -52 | -32 | -20 | -44 |
| Total liabilities | — | 1,471 | 1,476 | 1,336 | 1,492 | 1,545 |
| Total assets | — | 2,571 | 2,592 | 2,472 | 2,632 | 2,663 |
| Line item | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Cash from operations | 89 | 266 | -317 | 219 | -27 | 30 |
| Cash from financing | -77 | -139 | 238 | -231 | 14 | -72 |
Insider filings
1 filing, all on Mar 3, 2026.
Open market
decisions to buy or sellPurchases
$28.9K
1 purchase by 1 insider
Sales
None
No insider sold shares.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Rusnak-Carlson Sabrina | $28.9K | — | Mar 3, 2026 |
Latest filings (2)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Mar 3, 2026 | Rusnak-Carlson Sabrina General Counsel | Purchase | 2,300 | $28.9K |
| Mar 17, 2025 | Richer Clare Stack Director | Purchase | 1,530 | $25.1K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Bain Capital Specialty Finance, Inc.
Free account. Everything above stays public.
Write why you follow Bain Capital Specialty Finance, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading